Genetic susceptibility to preeclampsia: Roles of cytosine-to-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68–base pair insertion at nucleotide 844 of the gene for cystathionine β-synthase, and factor V Leiden mutation
- 1 May 2001
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 184 (6) , 1211-1217
- https://doi.org/10.1067/mob.2001.110411
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Preeclampsia and genetic risk factors for thrombosis: A case-control studyAmerican Journal of Obstetrics and Gynecology, 1999
- Factor V Leiden and Thermolabile Methylenetetrahydrofolate Reductase Gene Variants in an East Anglian Preeclampsia CohortHypertension, 1999
- Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsiaJournal of the Society for Gynecologic Investigation, 1999
- Detection of factor V Leiden mutation in severe pre‐eclamptic Hungarian womenClinical Genetics, 1998
- Elevated homocyst(e)ine levels with preeclampsiaPublished by Wolters Kluwer Health ,1998
- Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia.Journal of Medical Genetics, 1997
- The factor V Leiden mutation may predispose women to severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1996
- Underlying disorders associated with severe early-onset preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentaeThe Lancet, 1992